| 2021 | | 2021 clinical practice guidelines for diabetes mellitus in Korea | 김대중 |
| 2021 | | Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9) | 김대중 |
| 2021 | | Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data | 김대중 |
| 2021 | | Acute glucose shift induces the activation of the nlrp3 inflammasome in thp-1 cells | 강엽, 김대중, 김혜진, 이관우, 한승진 |
| 2021 | | Association between social network structure and physical activity in middle-aged Korean adults | 김대중 |
| 2021 | | Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19 | 김대중 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea | 김대중, 하경화 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings | 김대중, 하경화 |
| 2021 | | Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey | 김대중, 박범희, 정윤석, 최용준 |
| 2021 | | Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015) | 김대중 |
| 2021 | | Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Cardiovascular safety of sodium glucose cotransporter 2 inhibitors as add-on to metformin monotherapy in patients with type 2 diabetes mellitus | 김대중, 전자영, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study | 김대중, 이나미, 하경화, 한승진 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study | 김대중, 하경화 |
| 2020 | | Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | 김대중, 하경화 |
| 2020 | | Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea | 김대중, 박인휘, 이민정, 하경화 |
| 2020 | | Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea | 김대중 |
